P-6154

JCO Precision Oncology | 2026

Novel genomic biomarkers significantly improve post-HCT relapse risk stratification for patients with myelodysplastic neoplasms.

Zhang T, Auer PL, Dong J, Chen Z, Spellman SR, Saber W, Bolon YT

PubMed
PMID: 41576307

Abstract
Related Articles

CIBMTR Study #: BIO-20-08